vs
CACI INTERNATIONAL INC（CACI）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
CACI INTERNATIONAL INCの直近四半期売上が大きい（$2.2B vs $1.5B、Encompass Health Corpの約1.4倍）。Encompass Health Corpの純利益率が高く（9.5% vs 5.6%、差は3.9%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 5.7%）。CACI INTERNATIONAL INCの直近四半期フリーキャッシュフローが多い（$138.2M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 7.0%）
CACIインターナショナル社は米国を本拠とする多国籍の専門サービス・情報技術企業で、主に国防、情報機関、民生政府部門や一部の民間企業顧客に対し、カスタム技術ソリューション、サイバーセキュリティサービス、データ分析支援、重要ミッションの運用保障サービスを提供しています。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
CACI vs EHC — 直接比較
損益計算書 — Q2 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $2.2B | $1.5B |
| 純利益 | $123.9M | $146.1M |
| 粗利率 | — | — |
| 営業利益率 | 9.3% | 16.7% |
| 純利益率 | 5.6% | 9.5% |
| 売上前年比 | 5.7% | 9.9% |
| 純利益前年比 | 12.7% | 20.8% |
| EPS（希薄化後） | $5.59 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.2B | $1.5B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.0B | $1.3B | ||
| Q1 24 | $1.9B | $1.3B |
| Q4 25 | $123.9M | $146.1M | ||
| Q3 25 | $124.8M | $126.5M | ||
| Q2 25 | $157.9M | $142.1M | ||
| Q1 25 | $111.9M | $151.5M | ||
| Q4 24 | $109.9M | $120.9M | ||
| Q3 24 | $120.2M | $108.2M | ||
| Q2 24 | $134.7M | $114.1M | ||
| Q1 24 | $115.3M | $112.5M |
| Q4 25 | 9.3% | 16.7% | ||
| Q3 25 | 9.3% | 14.9% | ||
| Q2 25 | 9.0% | 16.2% | ||
| Q1 25 | 9.1% | 16.4% | ||
| Q4 24 | 8.6% | 14.3% | ||
| Q3 24 | 8.7% | 13.6% | ||
| Q2 24 | 9.7% | 14.3% | ||
| Q1 24 | 9.4% | 13.6% |
| Q4 25 | 5.6% | 9.5% | ||
| Q3 25 | 5.5% | 8.6% | ||
| Q2 25 | 6.9% | 9.7% | ||
| Q1 25 | 5.2% | 10.4% | ||
| Q4 24 | 5.2% | 8.6% | ||
| Q3 24 | 5.8% | 8.0% | ||
| Q2 24 | 6.6% | 8.8% | ||
| Q1 24 | 6.0% | 8.5% |
| Q4 25 | $5.59 | $1.43 | ||
| Q3 25 | $5.63 | $1.24 | ||
| Q2 25 | $7.11 | $1.39 | ||
| Q1 25 | $5.00 | $1.48 | ||
| Q4 24 | $4.88 | $1.18 | ||
| Q3 24 | $5.33 | $1.06 | ||
| Q2 24 | $5.97 | $1.12 | ||
| Q1 24 | $5.13 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $423.0M | $72.2M |
| 総負債低いほど良い | $3.0B | $2.4B |
| 株主資本純資産 | $4.1B | $2.4B |
| 総資産 | $8.9B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.72× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $423.0M | $72.2M | ||
| Q3 25 | $133.0M | $48.7M | ||
| Q2 25 | $106.2M | $99.1M | ||
| Q1 25 | $223.9M | $95.8M | ||
| Q4 24 | $175.7M | $85.4M | ||
| Q3 24 | $440.7M | $147.8M | ||
| Q2 24 | $134.0M | $154.4M | ||
| Q1 24 | $159.2M | $134.4M |
| Q4 25 | $3.0B | $2.4B | ||
| Q3 25 | $2.8B | $2.4B | ||
| Q2 25 | $2.9B | $2.3B | ||
| Q1 25 | $3.1B | $2.3B | ||
| Q4 24 | $3.1B | $2.4B | ||
| Q3 24 | $1.8B | $2.3B | ||
| Q2 24 | $1.5B | $2.7B | ||
| Q1 24 | $1.7B | $2.7B |
| Q4 25 | $4.1B | $2.4B | ||
| Q3 25 | $4.0B | $2.4B | ||
| Q2 25 | $3.9B | $2.3B | ||
| Q1 25 | $3.7B | $2.2B | ||
| Q4 24 | $3.7B | $2.1B | ||
| Q3 24 | $3.7B | $2.0B | ||
| Q2 24 | $3.5B | $1.8B | ||
| Q1 24 | $3.4B | $1.7B |
| Q4 25 | $8.9B | $7.1B | ||
| Q3 25 | $8.7B | $6.9B | ||
| Q2 25 | $8.6B | $6.8B | ||
| Q1 25 | $8.6B | $6.6B | ||
| Q4 24 | $8.5B | $6.5B | ||
| Q3 24 | $7.2B | $6.5B | ||
| Q2 24 | $6.8B | $6.4B | ||
| Q1 24 | $6.8B | $6.2B |
| Q4 25 | 0.72× | 1.00× | ||
| Q3 25 | 0.69× | 1.01× | ||
| Q2 25 | 0.75× | 1.02× | ||
| Q1 25 | 0.84× | 1.08× | ||
| Q4 24 | 0.82× | 1.14× | ||
| Q3 24 | 0.50× | 1.20× | ||
| Q2 24 | 0.44× | 1.46× | ||
| Q1 24 | 0.50× | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $154.2M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $138.2M | $116.7M |
| FCFマージンFCF / 売上 | 6.2% | 7.6% |
| 設備投資強度設備投資 / 売上 | 0.7% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 1.24× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $634.3M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $154.2M | $346.0M | ||
| Q3 25 | $171.1M | $270.8M | ||
| Q2 25 | $156.0M | $270.2M | ||
| Q1 25 | $230.3M | $288.6M | ||
| Q4 24 | $126.0M | $278.8M | ||
| Q3 24 | $34.7M | $267.8M | ||
| Q2 24 | $157.2M | $217.4M | ||
| Q1 24 | $198.3M | $238.8M |
| Q4 25 | $138.2M | $116.7M | ||
| Q3 25 | $154.1M | $83.7M | ||
| Q2 25 | $128.0M | $113.3M | ||
| Q1 25 | $214.1M | $125.5M | ||
| Q4 24 | $116.1M | $80.1M | ||
| Q3 24 | $23.2M | $120.3M | ||
| Q2 24 | $134.6M | $60.5M | ||
| Q1 24 | $186.6M | $99.4M |
| Q4 25 | 6.2% | 7.6% | ||
| Q3 25 | 6.7% | 5.7% | ||
| Q2 25 | 5.6% | 7.8% | ||
| Q1 25 | 9.9% | 8.6% | ||
| Q4 24 | 5.5% | 5.7% | ||
| Q3 24 | 1.1% | 8.9% | ||
| Q2 24 | 6.6% | 4.6% | ||
| Q1 24 | 9.6% | 7.6% |
| Q4 25 | 0.7% | 14.8% | ||
| Q3 25 | 0.7% | 12.7% | ||
| Q2 25 | 1.2% | 10.8% | ||
| Q1 25 | 0.7% | 11.2% | ||
| Q4 24 | 0.5% | 14.1% | ||
| Q3 24 | 0.6% | 10.9% | ||
| Q2 24 | 1.1% | 12.1% | ||
| Q1 24 | 0.6% | 10.6% |
| Q4 25 | 1.24× | 2.37× | ||
| Q3 25 | 1.37× | 2.14× | ||
| Q2 25 | 0.99× | 1.90× | ||
| Q1 25 | 2.06× | 1.90× | ||
| Q4 24 | 1.15× | 2.31× | ||
| Q3 24 | 0.29× | 2.48× | ||
| Q2 24 | 1.17× | 1.91× | ||
| Q1 24 | 1.72× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CACI
| Service Other | $876.3M | 39% |
| Intelligence Community | $539.0M | 24% |
| Federal Civilian Agencies | $438.6M | 20% |
| Subcontractor | $202.5M | 9% |
| Other | $148.5M | 7% |
| Commercial And Other | $15.2M | 1% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
